Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 2 years
- Director since
- 2024
2 years of board service in total across 1 board, counting each seat separately. Longest: Passage Bio Inc., 2 years.
Passage Bio Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 3, 2025 | Ultragenyx Pharmaceutical Inc. | Open-market sale | −6,028 | $42.10 | $253,779 |
| Mar 3, 2025 | Ultragenyx Pharmaceutical Inc. | Shares withheld for tax | −508 | $42.92 | $21,803 |
| Mar 1, 2025 | Ultragenyx Pharmaceutical Inc. | Grant or award | +18,443 | — | — |
Questions about Thomas Richard Kassberg
What boards is Thomas Richard Kassberg on?
Thomas Richard Kassberg sits on the board of Passage Bio Inc.
How long has Thomas Richard Kassberg served on boards?
Our records show at least 2 years of board service across 1 board, the earliest from 2024.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.